Tumors of the kidneys: New entities;Tumeurs du rein: Les nouvelles entités

Annales de Pathologie

Volumn 25, Issue 2, 2005, Pages 117-133

  Compérat, Éva ^a   Vasiliu, Viorel ^b   Ferlicot, Sophie ^c   Camparo, Philippe ^d   Sibony, Mathilde ^e   Vieillefond, Annick ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c BICÊTRE HOSPITAL   (France)

^d Hôpital des Instructions d'Armée Val de Grâce   (France)

^e HÔPITAL TENON   (France)

^f Hôpital Cochin ^*  (France)

Author keywords

Benign mixed epithelial and stromal tumor; Epithelioid angiomyolipoma; Kidney tumors; Low grade mucinous tubular renal carcinoma; Multilocular clear cell renal carcinoma; Xp11 translocation carcinoma

Indexed keywords

ANGIOMYOLIPOMA; ARTICLE; BIRT HOGG DUBE SYNDROME; CANCER GRADING; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; CLEAR CELL CARCINOMA; DISEASE ASSOCIATION; EPITHELIUM TUMOR; HUMAN; IMMUNOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MIXED TUMOR; MUCINOUS CARCINOMA; ONCOCYTOMA; TUMOR CLASSIFICATION;

EID: 22944470860     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(05)86175-9     Document Type: Article

References (77)

1. Molinié V, Cochand-Priollet B, Staroz F, Vieillefond A. Classification des tumeurs primitives du rein de l'adulte. Ann Pathol 1998; 18: 29-47.
2. Bostwick DG, Eble JN, Murphy GP. Conference Summary. Diagnosis and prognosis of Renal Cell Carcinoma: 1997 Workshop, Rochester, Minnesota March 21-22 1997. Cancer 1997; 80: 975-97.
3. WHO classification of tumors. Tumours of the genitourinary and male genital organs. Ed Eble JN, Sauter G, Epstein JI, Sesterhenn IA, Lyon IARC Press 2004.
4. Eble JN, Bonsib SM. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 1998; 15: 2-20.
5. Pellerin M, Coquille F, Molinié V, Rebibo G. Masses liquidiennes des reins. Feuil Radiol 2003; 43: 379-90.
6. Nassir A, Jollimore J, Gupta R, Bell D, Norman R. Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature. Urology 2002; 60: 421-7.
7. Bloom TL, Gray Sears CL, Williams TR, Linfesty RL, Amling CL. Multilocular cystic renal cell carcinoma with osseous metaplasia in a 25-year-old woman. Urology 2003; 61: 462.
8. Imura J, Ichikawa K, Takeda J, Tomita S, Yamamoto H, Nakazono M et al. Multilocular cystic renal cell carcinoma: a clinicopathological, immuno- and lectin histochemical study of nine cases. APMIS 2004; 112: 183-91.
9. Fromowitz FB, Watson RA, Kansal NS, Barbashina V, Esposito M, Irwin RJ Jr. "Indeterminate" cystic lesion of the kidney partially lined by small cells with clear cytoplasm -malignant or benign? Urology 2003; 61: 1259.
10. Castillo OA, Boyle ET Jr, Kramer SA. Multilocular cysts of kidney. A study of 29 patients and review of literature. Urology 1991; 37: 156-62.
11. Imbert MC, Gerard-Marchant R, Schweisguth O, Nezelof C. Carcinome tubulo-papillaire du rein chez l'enfant: à propos de 9 observations. Ann Pediatr 1968; 15: 1094-104.
12. Argani P, Antonescu CR, Couturier J, Fournet JC, Boccon-Gibod L, Ladanyi M et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002; 26: 1553-66.
13. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Ladanyi M et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159: 179-92.
14. Argani P, Ladanyi M. Recent advances in pediatric renal neoplasia. Adv Anat Pathol 2003; 10: 243-60.
15. Zambrano E, Reyes-Mugica M. Renal cell carcinoma with t(X;17): singular pediatric neoplasm with specific phenotype/genotype features. Pediatr Dev Pathol 2003; 6: 84-7.
16. Vedrine L, Duvic C, Camparo P, Herody M, Seris P, Nedelec G. Carcinome à cellules claires avec une translocation X;1 révélé par une hématurie microscopique. Ann Med Interne 2001; 152: 59-61.
17. Perot C, Boccon-Gibod L, Fournet JC, Freneaux P, Vieillefond A, Couturier J et al. Five new cases of juvenile renal cell carcinoma with translocations involving Xp 11.2: a cytogenetic and morphologic study. Cancer Genet Cytogenet 2003; 143: 93-9.
18. Desangles F, Camparo P, Fouet C, Houlgatte A, Arborio M. Translocation (X;1) associated with a nonpapillary carcinoma in a young woman: a new definition for an Xp11.2 RCC subtype. Cancer Genet Cytogenet 1999; 113: 141-4.
19. Weterman MA, van Groningen JJ, den Hartog A, Geurts van Kessel A. Transformation capacities of the papillary renal cell carcinoma-associated PRCCTFE3 and TFE3PRCC fusion genes. Oncogene 2001; 20: 1414-24.
20. Perot C, Bougaran J, Boccon-Gibod L, Storkel S, Leverger G, Couturier J et al. Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet Cytogenet 1999; 110: 54-6.
21. Argani P, Lui MY, Couturier J, Bouvier R, Foumet JC, Ladanyi M. A novel CLTC - TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 2003; 22: 5374-8.
22. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 2002; 27: 750-61.
23. Eble JN. Mucinous tubular and spindle cell carcinoma and post neuroblastoma carcinoma: newly recognised entities in the renal carcinoma family. Pathology 2003; 6: 499-504.
24. He Q, Ohaki Y, Mori O, Asano G, Tuboi N. A case report of renal cell tumor in a 45-year-old female mimicking lower portion nephrogenesis. Pathol Int 1998; 48: 416-20.
25. Parwani AV, Husain AN, Epstein JI, Beckwith JB, Argani P. Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol 2001; 32: 506-12.
26. Otani M, Shimizu T, Serizawa H, Ebihara Y, Nagashima Y. Low-grade renal cell carcinoma arising from the lower nephron: a case report with immunohistochemical, histochemical and ultrastructural studies. Pathol Int 2001; 51: 954-60.
27. Rakozy C, Schmahl GE, Bogner S, Störkel S. Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol 2002; 15: 1162-71.
28. Hes O, Hora M, Perez-Montiel DM, Suster S, Curik R, Sokol L et al. Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/spindle and cuboidal renal cell carcinoma components. Histopathology 2002; 4: 549-55.
29. Leroy X, Aubert S, Gosselin B. Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation: a distinct clinicopathologic entity? Hum Pathol 2002; 33: 574-75.
30. Ferlicot S, Allory Y, Dimet S, Compérat E, Sibory M, Vieillefond A. Mucinous tubular and spindle cell renal carcinoma: a report of 15 cases with a review of the literature. Virchows Arch 2005; sous presse.
31. Weber A, Srigley J, Moch H. Mucinous spindle cell carcinoma of the kidney. A molecular analysis. Pathologe 2003; 24: 453-59.
32. Picken MM, Curry JL, Lindgren V, Clark JI, Eble JN. Metanephric adenosarcoma in a young adult: morphologic, immunophenotypic, ultrastructural, and fluorescence in situ hybridization analyses: a case report and review of the literature. Am J Surg Pathol 2001; 25: 1451-7.
33. Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol 1997; 21: 1123-30.
34. Martignoni, G, Pea M, Bonetti F, Zamboni G, Carbonara C, Longa L et al. Carcinomalike monotype epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathological and genetic study. Am J Surg Pathol 1998; 22: 663-72.
35. Pea M, Bonetti F, Martignoni G, Henske EP, Manfrin E, Colato C et al. Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol 1998; 22: 180-7.
36. Stone CH, Lee MW, Amin MB, Yaziji H, Gown AM, Ro JY et al. Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med 2001; 125: 751-8.
37. Bernardini S, Chabannes E, Algros MP, Billerey C, Bittard H. Variants of renal angiomyolipoma closely simulating renal cell carcinoma: difficulties in the histological diagnosis. Urol Int 2002; 69: 78-81.
38. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol 2002; 26: 493-7.
39. L'Hostis H, Deminiere C, Ferriere JM, Coindre JM. Renal angiomyolipoma. A clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol 1999; 23: 1011-20.
40. Leroy X, Moukassa D, Gosselin B. Renal epithelioid angiomyolipoma. A clinicopathological and immunohistochemical study of three cases. J Urol Pathol 1999; 11: 59-67.
41. Cibas ES, Goss GA, Kulke MH, Demetri GD, Fletcher CDM. Malignant epithelioid angiomyolipoma (Sarcoma ex angiomyolipoma) of the Kidney. A case report and review of the literature. Am J Surg Pathol 2001; 25: 121-6.
42. Ribalta T, Lioreta J, Munne A, Serrano S, Cardesa A. Malignant pigmented clear cell epithelioid tumor of the kidney: clear cell ("sugar") tumor versus malignant melanoma. Hum Pathol 2000; 31: 516-9.
43. Ong A, Pinto P, Kim F, Kavoussi L. Recurrent renal epithelioid angiomyolipoma. Urology 2003; 61: 1035.
44. Yamamoto T, Ito K, Suzuki K, Yamanaka H, Ebihara K, Sasaki A. Rapidly progressive malignant epithelioid angiomyolipoma of the kidney. J Urol 2002; 168: 190-1.
45. Kawaguchi K, Oda Y, Nakanishi K, Saito T, Tamiya S, Nakahara K et al. Malignant transformation of renal angiomyolipoma: a case report. Am J Surg Pathol 2002; 26: 523-29.
46. Bonetti F, Martignoni G, Manfrin E, Gambacorta M, Faleri M, Bacchi C et al. Abdominopelvic sarcoma of perivascular epithelioid cells. Report of four cases in young women, one with tuberous sclerosis. Mod Pathol 2001; 14: 563-68.
47. Martignoni G, Bonetti F, Pea M, Tardanico R, Brunelli M, Eble JN. Renal disease in adults with TSC2/ PKD1 contiguous gene syndrome. Am J Surg Pathol 2002; 26: 198-205.
48. Michal M, Syrucek M. Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract 1998; 194: 445-8.
49. Michal M. Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract 2000; 196: 275-6.
50. Adsay V, Eble J, Srigley JR, Jones CJ, Grignon DJ. Mixed epithelial and stromal tumor of the kidney. Am J Surg Pathol 2000; 24: 958-70.
51. Pawade J, Soosay GN, Delprado W, Parkinson MC, Rode J. Cystic hamartome of the renal pelvis. Am J Surg Pathol 1993; 17: 1169-75.
52. Mensch LS, Trainer TD, Plante MK. Cystic hamartoma of renal pelvis: rare pathologic entity. Mod Pathol 1999; 12: 417-20.
53. Daniel L, Lechevallier E, Bouvier C, Coulange C, Pellissier J-F. Adult mesoblastic nephroma. Pathol Res Pract 2000; 196: 135-9.
54. Dorel le Theo M, Audard V, Peyromaure M, Ouazana D, Vieillefond A. Une tumeur inhabituelle du rein. Ann Pathol (sous presse).
55. Compérat E, Couturier J, Peyromaure M, Cornud F, Vieillefond A. Benign mixed epithelial and stromal tumor of the kidney (MEST) with cytogenetic alteration. Pathol Res Pract (sous presse).
56. Beiko DT, Nickel JC, Boag AH, Srigley JR. Benign mixed epithelial stromal tumor of the kidney of possible Müllerian origin. J Urol 2001; 166: 1381-2.
57. Pierson CR, Schober MS, Wallis T, Sarkar FH, Sorensen PH, Eble JN et al. Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congential mesoblastic néphrome. Hum Pathol 2001;32:513-20.
58. Svec A, Hes O, Michal M, Zachoval R. Malignant epithelial and stromal tumor of the kidney. Virchows Arch 2001; 439: 700-2.
59. Weirich G, Glenn G, Junker K, Merino M, Störkel S, Lubensky I et al. Familial renal oncocytoma: clinicopathological study of 5 families. J Urol 1998; 160: 335-40.
60. Tickoo SK, Reuter VE, Amin MB, Srigley JR, Epstein JI, Min KW et al. Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol 1999; 23: 1094-101.
61. Noguchi S, Nagashima Y, Shuin T, Kubota Y, Kitamura H, Yao M et al. Renal oncocytoma containing "chromophobe" cells. Int J Urol 1995; 2: 279-80.
62. Tickoo SK, Amin MB. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma: analysis of their potential utility in the differential diagnosis. Am J Clin Pathol 1998; 110: 782-7.
63. Pavlovich CP, Walther MM, Eyler RA, Hewitt SM, Zbar B, Linehan WM et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 2002; 26: 1542-52.
64. Cochand-Priollet B, Molinie V, Bougaran J, Bouvier R, Dauge-Geffroy MC, Deslignieres S et al. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical and immunohistochemical study of 124 cases. Arch Pathol Lab Med 1997; 121: 1081-6.
65. Bazille C, Allory Y, Molinie V, Vieillefond A, Cochand-Priollet B, Cussenot O et al. Caracterisation immunohistochimique des principaux types histologiques de tumeurs rénales épithéliales étudiées par tissue-arrays sur une série de 310 cas. Ann Pathol (sous presse).
66. Al-Saleem T, Cairns P, Dulaimi EA, Feder M, Testa JR, Uzzo RG. The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genet Cytogenet 2004; 152: 23-8.
67. Roth JS, Rabinowitz AD, Benson M, Grossman ME. Bilateral renal cell carcinoma in the Birt-Hogg-Dube syndrome. J Am Acad Dermatol 1993; 29: 1055-6.
68. Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B et al. Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol 1999; 135: 1195-202.
69. Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol 2003; 170: 2163-72.
70. Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML et al. Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues. Mod Pathol 2004; 17: 998-1011.
71. Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K et al. Inactivation of BHD in sporadic renal tumors. Cancer Res 2003; 63: 4583-7.
72. Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R et al. Clinical and genetic studies of Birt-Hogg-Dube syndrome. J Med Genet 2002; 39: 906-12.
73. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol 1998; 15: 54-67.
74. Peyromaure M, Thiounn N, Scotté F, Vieillefond A, Debŕ B, Oudard S. Collecting duct carcinoma of the kidney: a clinicopathoiogical study of nine cases. J Urol 2003; 170: 1138-40.
75. Kafé H, Verbavatz JM, Cochand-Priollet B, Castagnet P, Vieillefond A. Collecting duct carcinoma: an entity to be redefined? Virchow Arch (sous presse).
76. Amin MB, Mac Lennan, Paraf F, Cheville JC, Vieillefond A, Radhakrishan A et al. Tubulocystic carcinoma of the kidney: clinicopathoiogical analysis of a distinctive rare subtype of renal cell carcinoma. Mod Pathol 2004; 17 (suppl 1): 137a.
77. Milowsky MI, Rosmarin A, Tickoo SK, Papanicolaou N, Nanus DM. Active chemotherapy for collecting duct carcinoma of the kidney. Cancer 2002; 94: 111-16.